ZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2017

Continued sales growth during the third quarter; revenue increased by 2% compared with the previous year.  

Zinzino’s total revenues for the third quarter of 2017 amounted to 119.9 (117.6)* MSEK, corresponding to sales growth of 2% compared to the same period in 2016.  

Accumulated for January-September 2017, total revenues amounted to 344.6 (295.7)* MSEK, corresponding to an increase of 15%.  

Several markets showed strong growth. The newly established EU markets increased by 75% overall and Germany increased by 41%. In the Baltic countries, both Latvia and Lithuania increased by 35%, and the strong sales markets in Sweden and Finland increased by 31% and 15%, respectively. 

* Comparative figures adjusted per the new accounting policy regarding currency-related income and expenses.
 


For more information: 

Dag Bergheim Pettersen, CEO Zinzino, Tel. +47 93 22 57 00 www.zinzino.se  


Pictures for publication free of charge:
Marcus Tollbom, Tel. + 46 (0) 70-190 03 12 
Certified Adviser:
Erik Penser, Bank Aktiebolag  

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11.00 on 9th of October 2017.  

Zinzino Nordic AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActie Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, and in Florida, USA. Zinzino is a public company and its shares are listed on Nasdaq First North. In 2016, Zinzino was recognized with the award ‘’Superföretag 2015’’ by Veckans Affärer and the ‘’Gazelle’’ award by Dagens Industri.

Tags:

About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, Norway, Iceland and in North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo and in Florida, United States. Zinzino is a public limited company and its shares are listed on Nasdaq First North.

Subscribe

Documents & Links